Current Care Guideline «Syvä laskimotukos ja keuhkoembolia»1 and Summary «Syvä laskimotukos ja keuhkoembolia»2 in Finnish
Key recommendations in management of VTE include prompt and systematic diagnostics based on clinical probability, D-dimer testing and imaging studies, and individualized antithrombotic treatment. Outpatient management is encouraged for patients with favourable prognosis. Interventions such as thrombolysis, venous stenting and inferior vena cava filters are limited to specific subgroups of patients.
The duration of anticoagulation is tailored by balancing the risks of VTE recurrence and bleeding. Without contraindications, the minimal duration of anticoagulation is 3 months. The selection between warfarin, direct oral anticoagulants (apixaban, dabigatran, rivaroxaban) and low molecular weight heparin is based on individual patient characteristics and suitability of each drug.
Riitta Lassila (Chair)
Elina Armstrong
Veli-Pekka Harjola
Risto Kaaja
Hannu Manninen
Tuula Meinander
Pirjo Mustonen